In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
The levels of influenza activity in European countries reported by EISN members during the influenza season are based on three assessments: An indicator of the overall intensity of influenza activity in the country, An indicator of the geographical spread of influenza in the country, An indicator of trend in ILI/ARI sentinel consultations in the country compared to the previous week.
February 2013, European Centre for Disease Prevention and Control (ECDC) and representatives of Vaccines Europe met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of influenza.
A two-day regional workshop of CONSISE (the Consortium for the Standardization of Influenza Seroepidemiology), including regional partners from East and South East Asia actively engaged in the development of the influenza seroepidemiology protocols and laboratory standardisation work or willing to undertake field work.
Two prophylactic HPV vaccines have been licensed in Europe, a bivalent and a quadrivalent vaccine: both have a good safety profile and protect against the high-risk HPV types 16 and 18.